To evaluate the clinical importance of PD-1/PD-L1, we estimated the Youden index of PD-1/PD-L1 expression and classified the ICC patients into high and low expression groups on the basis of a cut-off value of positive immunostaining in tumor tissue. The gene discussed is PDCD1; the disease is intrahepatic cholangiocarcinoma.